Mounjaro and B12 Deficiency: What You Should Know

What the clinical trial data tells us about tirzepatide and B12

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks and generated the most detailed tirzepatide safety dataset available. Reviewing its published adverse-event data, B12 deficiency did not emerge as a notable finding associated with tirzepatide use. That is meaningful, though it is not the whole story. Clinical trials are powered to detect events that occur at a certain frequency; subtle shifts in nutritional status in a subgroup may not reach the threshold for a reported adverse event even when they are clinically relevant for individuals.

The more established nutrient concern with GLP-1 class medicines relates to muscle mass rather than micronutrients: rapid weight loss of any kind carries a risk of lean tissue loss alongside fat. For micronutrients specifically, the NHS tirzepatide information page does not list B12 depletion among the recognised side effects or cautions, which is consistent with the trial data. So the short answer to whether Mounjaro can cause B12 deficiency is: not directly, and not as a recognised pharmacological effect.

Where the question gets more nuanced is the indirect route. If you want to understand how B12 and Mounjaro interact in more depth, that page works through the relationship in detail. Tirzepatide works partly by slowing how quickly the stomach empties, which extends the feeling of fullness and reduces overall calorie intake. People on treatment often eat noticeably less, sometimes far less in the early months. If the foods that fall away first happen to be high-B12 foods (meat, fish, eggs, dairy), intake can quietly drop.

Who carries a higher background risk when starting Mounjaro

B12 deficiency already affects a meaningful proportion of the UK population before any treatment is factored in. It is worth being clear about which people are in a higher-risk group, because Mounjaro does not create this risk from scratch, it may amplify one that already exists.

Older adults absorb B12 less efficiently as intrinsic factor production declines with age. People following plant-based or vegan diets have no reliable dietary source of B12 at all unless they supplement or eat fortified foods. People with a history of gastric surgery, inflammatory bowel conditions, or coeliac disease may have pre-existing absorption difficulties. Anyone already taking metformin for type 2 diabetes (and Mounjaro is licensed for that indication) should be aware that metformin is associated with reduced B12 absorption over time, a point flagged in prescribing literature.

If any of these apply to you, it is worth raising them at your consultation rather than waiting to see how treatment goes. A baseline blood test is straightforward. Our clinical team reviews each person's full medical picture, not just BMI, before treatment is recommended. For a broader look at how Mounjaro relates to various vitamin and mineral concerns, that page covers the wider landscape.

The practical side: eating well enough on treatment

One misconception worth setting aside gently is that taking a supplement automatically resolves the problem. Supplements are useful, but the right response depends on what is actually happening: is intake low, or is absorption impaired? Those need different approaches, and a blood test tells you which situation you are in. Taking B12 preventively does no harm (it is water-soluble and excess is excreted) but it is not a substitute for knowing your baseline.

On treatment, the foods that tend to keep B12 intake steady are also the foods that support the muscle-preserving goals of treatment: eggs, lean meat, fish, dairy, and fortified cereals. Protein adequacy and B12 often travel together in practical dietary terms, so focusing on protein targets (something your prescriber or a dietitian can guide on) tends to keep micronutrient intake in reasonable shape at the same time.

If nausea in the early weeks of treatment is pushing you away from animal proteins specifically, that is worth mentioning to your prescriber rather than quietly managing alone. Nausea tends to ease once the body adjusts, and there are practical strategies to get through that period without letting nutrition slip significantly. You can read more about how tirzepatide's dosing schedule works and why side effects tend to cluster around the early and dose-increase stages.

The broader picture of iron and other nutrients is a related conversation: iron deficiency alongside Mounjaro follows similar logic and is worth reading if you are thinking about nutritional monitoring more generally. There is also a dedicated page on how tirzepatide and B12 interact for those who want more detail on the relationship between the two. Anyone with particular concerns can also reach our team directly, aftercare support runs seven days a week.